Pegloticase response rates higher when co-treated with immunomodulating therapy in gout patients Dr Supreeth D R11 Dec 2022 8:00 PM ISTPatients with uncontrolled/refractory gout have heavy disease burden, but few treatment options. Pegloticase lowers serum urate (SU), but anti-drug...
Febuxostat demonstrates efficacy and renal safety in patients with gout and CKD Dr Supreeth D R23 Nov 2022 8:00 PM ISTPeiyu Zhang et al conducted a study to explore the efficacy and renal safety of febuxostat in gout and stage 2-4 chronic kidney disease (CKD) and...
Ustekinumab effective long term treatment for active Psoriatic Arthritis: SUSTAIN Study data Dr Supreeth D R16 Nov 2022 8:00 PM ISTPsoriatic arthritis (PsA) is a chronic, progressive disease that places a significant burden on patients and healthcare systems. The SUSTAIN study...
